With Added Organic Compound Patents (Class 424/638)
  • Patent number: 11650214
    Abstract: The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: May 16, 2023
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Université de Côte d'Azur, CHU de Nice
    Inventors: Thierry Passeron, Florence Joly
  • Patent number: 11596663
    Abstract: Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E, or selenium. Other compounds are Zinc, Vitamin E, Vitamin C, Quercetin, L-glutamine and Robuvit. Diagnosing an oxidative stress (OS) in a mammal detects an OS biomarker, selectively isoprostane and other antioxidant biomarkers such as HODE, microRNAs, TAC, GSH, MDA, and TNF-alpha. The sample can be saliva.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: March 7, 2023
    Assignee: HEMOPET
    Inventor: Winifred Jean Dodds
  • Patent number: 11406681
    Abstract: Managing and treating elevated OS biomarkers in mammals such as companion animals with at least one of the supplements alpha-lipoic acid, carnitine, co-enzyme Q-10, ginger, green tea, licorice, milk thistle, garlic, honey. resveratrol, soybeans, tomatoes, turmeric, vitamin D, vitamin E or selenium. Diagnosing an oxidative stress (OS) in a mammal comprises collecting a sample; screening the sample to detect the presence of an OS biomarker, selectively isoprostane and other antioxidants such as HODE microRNAs. TAC: GSH, MDA, and TNF-alpha. The sample can be saliva.
    Type: Grant
    Filed: October 14, 2021
    Date of Patent: August 9, 2022
    Assignee: HEMOPET
    Inventor: Winifred Jean Dodds
  • Patent number: 11317627
    Abstract: There are provided a soybean disease control composition containing, as active ingredients, (a) fluazinam or a salt thereof and (b) at least one fungicide selected from the group consisting of carboxamide-based compounds and azole-based compounds; and a method for controlling a soybean disease, which includes applying the soybean disease control composition to a soybean plant or soil.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: May 3, 2022
    Assignee: ISHIHARA SANGYO KAISHA, LTD.
    Inventors: Hiroyuki Hayashi, Koudai Yamamoto
  • Patent number: 11260014
    Abstract: A cosmetic composition is disclosed for applying to skin. The composition includes a liquid and dispersed in the liquid: any amount or form of fucoidan, any amount or form of beta glucan; and any amount of a marine extract. When the cosmetic composition is applied to the skin, the appearance of the skin is improved.
    Type: Grant
    Filed: October 8, 2020
    Date of Patent: March 1, 2022
    Assignee: Skinergistics Clinical Skin Solutions Inc.
    Inventor: Gina Athwal
  • Patent number: 10813910
    Abstract: The present invention discloses an herbal anti-AMD composition for treatment of age related macular diseases (AMD). More specifically, the present invention relates to an herbal composition for the prevention, management and treatment of neo-vascular or wet AMD.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 27, 2020
    Assignee: Vivek Anand Parachur
    Inventor: Vivek Anand Parachur
  • Patent number: 10791737
    Abstract: There are provided a soybean disease control composition containing, as active ingredients, (a) fluazinam or a salt thereof and (b) at least one fungicide selected from the group consisting of carboxamide-based compounds and azole-based compounds; and a method for controlling a soybean disease, which includes applying the soybean disease control composition to a soybean plant or soil.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: October 6, 2020
    Assignee: ISHIHARA SANGYO KAISHA, LTD.
    Inventors: Hiroyuki Hayashi, Koudai Yamamoto
  • Patent number: 10729139
    Abstract: An antimicrobial composition is disclosed that contains an acid-solubilized copper ammonium or copper-zinc ammonium complex that is effective against microorganisms such as nosocomial or environmental bacteria, fungi, viruses, and the like. The antimicrobial composition can be used in the preparation of a medicament for treating microbes or a microbial infection, and may contain a carrier to create a cream, soap, wash, spray, dressing, cleanser, cosmetic product, topical drug product, or other antimicrobial product.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: August 4, 2020
    Assignee: Myco Sciences Limited
    Inventor: Tony John Hall
  • Patent number: 10583154
    Abstract: The present invention relates to non-mercurial preservatives, including antimicrobial polyamide polymers and octenidine, and to methods of use thereof to produce preservative-containing multi-dose formulations. The preservative-containing multi-dose formulations exhibit resistance to one or more contaminating microorganisms, and have advantageous properties with respect to long term stability of biological and small molecule active ingredients.
    Type: Grant
    Filed: April 13, 2017
    Date of Patent: March 10, 2020
    Assignees: Boehringer Ingelheim Animal Health USA Inc., GENZYME CORPORATION
    Inventors: Guillaume Rigaut, Celine Loss-Dunod, Alexis Guy Andre Lucien Parisot, Pradeep K. Dhal
  • Patent number: 10517295
    Abstract: There are provided a soybean disease control composition containing, as active ingredients, (a) fluazinam or a salt thereof and (b) at least one fungicide selected from the group consisting of carboxamide-based compounds and azole-based compounds; and a method for controlling a soybean disease, which includes applying the soybean disease control composition to a soybean plant or soil.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: December 31, 2019
    Assignee: ISHIHARA SANGYO KAISHA, LTD.
    Inventors: Hiroyuki Hayashi, Koudai Yamamoto
  • Patent number: 10286006
    Abstract: A trace element solution comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable therapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvants. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocyclic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocyclic lactones include doramectin, ivermectin, abamectin and moxidectin.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: May 14, 2019
    Assignee: WARBURTON TECHNOLOGY LIMITED
    Inventors: Robert N. Laurie, William A. Smith
  • Patent number: 10172883
    Abstract: The invention described herein is directed to copper-containing compounds for the treatment of toxin exposure (including pore-forming toxin exposure) in a subject in need thereof. The invention is further directed to methods of treating toxin exposure in a subject in need thereof.
    Type: Grant
    Filed: June 9, 2015
    Date of Patent: January 8, 2019
    Assignee: ALATALAB SOLUTION, LLC
    Inventor: Angel A. Yanagihara
  • Patent number: 9950008
    Abstract: Risk of visual impairment including Age-Related Macular Degeneration (AMD) and cataracts increase with age. This increased risk can be caused by changes in the structure and function of the eye or changes in structures of the central nervous system that support visual perception. The present invention comprises fruit flavored, chewable formulations of supplements for reducing the risk of AMD. Chewable dosage forms of the invention are preferred over other formulations and may increase compliance in an aging population, who are more likely to require an eye health supplement and have an increased risk of experiencing dysphagia.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: April 24, 2018
    Inventors: Marc Bellemore, Megan Thomas, Ashley V Kasurak, Paul Charlton, John Doherty, Sorin Popa
  • Patent number: 9951117
    Abstract: This document provides methods and materials related to vesicular stomatitis viruses. For example, vesicular stomatitis viruses, nucleic acid molecules encoding VSV polypeptides, methods for making vesicular stomatitis viruses, and methods for using vesicular stomatitis viruses to treat cancer are provided.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: April 24, 2018
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Stephen James Russell, Shruthi Naik
  • Patent number: 9763968
    Abstract: Formulations of cross-linkable polymers, capable of forming non-toxic and biocompatible hydrogels in situ, containing at least one of doxycycline or minocycline. Methods of using the hydrogels for treating the skin or ocular tissues of mammals exposed to vesicant compounds such as sulfur mustard (SM), nitrogen mustard (NM) or half mustard (2-chloroethyl ethyl sulfide (CEES)) are also disclosed.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: September 19, 2017
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Patrick J. Sinko, Manjeet Deshmukh, Siva N. Priya Anumolu, Anupa R. Menjoge, Marion K. Gordon
  • Patent number: 9750823
    Abstract: Recombinant vectors in which expression of one or more elements (e.g. genes required for viral replication, detectable imaging agents, therapeutic agents, etc.) is driven by a truncated CCN 1 cancer selective promoter (tCCN1-Prom) are provided, as are cells and transgenic animals that contain such vectors. The vectors are used in cancer therapy and/or diagnostics, and the transgenic mice are used to monitor cancer progression, e.g. in screening assays.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: September 5, 2017
    Inventors: Paul B. Fisher, Swadesh K. Das, Rupesh Dash, Devanand Sarkar, Siddik Sarkar, Jolene Windle
  • Patent number: 9725477
    Abstract: Disclosed are a class of platinum compounds of malonic acid derivatives having a leaving group containing an amino or alkylamino, and pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition containing the compounds. Also disclosed are uses of the compounds for treating cell proliferative diseases especially cancers. The platinum compounds of the present invention have high solubility in water, low toxicity and strong anti-tumor effect.
    Type: Grant
    Filed: November 15, 2013
    Date of Patent: August 8, 2017
    Assignee: BEIJING FSWELCOME TECHNOLOGY DEVELOPMENT CO., LTD
    Inventors: Xiaoping Chen, Yashi Yan, Xiaoping Meng, Feng Zhao, Zejun Gao, Shouming Wen
  • Patent number: 9629846
    Abstract: The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of one or more folic acid materials, vitamins and minerals and a nutritionally acceptable carrier therefor. The invention describes specific nutritional supplements for the uses set forth above.
    Type: Grant
    Filed: March 23, 2016
    Date of Patent: April 25, 2017
    Assignee: Argent Development Group, LLC
    Inventors: Kenneth R. Greathouse, Rhett Sean Daniels
  • Patent number: 9622999
    Abstract: Compositions for increasing the rate of metabolism of alcohol in a human and preventing the symptoms of a hangover comprising amino acids of one or both of L-arginine or L-citrulline; one or more of L-glutamine, L-glutamic acid, L-glutamine or theanine; and one or both of L-tyrosine or L-phenylalanine. The compositions may also contain other ingredients, such as B vitamins and plant extracts.
    Type: Grant
    Filed: November 6, 2014
    Date of Patent: April 18, 2017
    Inventor: Salim Jarrouj
  • Patent number: 9565858
    Abstract: Compositions which impart a microbicidal benefit to treated surfaces which compositions comprise (or in certain preferred embodiments may consist essentially of, or may consist of): a zinc ion source material which releases zinc ions into the treatment composition, preferably a source of Zn++ ions; preferably at least from about 20% wt.
    Type: Grant
    Filed: June 28, 2013
    Date of Patent: February 14, 2017
    Assignee: RECKITT BENCKISER LLC
    Inventors: Mohammad Khalid Ijaz, Yun-Peng Zhu
  • Patent number: 9539282
    Abstract: The invention concerns a kit for preventing or treating oxidative stress in humans or animals by means of therapeutically active hydrogen molecules. The hydrogen molecules are formed by reacting a base metal with aqueous acids or bases and by reacting a saline hydride with water or aqueous acids.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: January 10, 2017
    Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V.
    Inventor: Kurt Lucas
  • Patent number: 9486409
    Abstract: The present invention provides nanoparticle compositions including one or more peptides. The present invention achieves transdermal delivery of such peptides without the need for peptide modification, or for use of chemical or mechanical abrasion or disruption of skin.
    Type: Grant
    Filed: February 22, 2014
    Date of Patent: November 8, 2016
    Assignee: Anterios, Inc.
    Inventors: Jonathan Edelson, Timothy Kotyla
  • Patent number: 9439913
    Abstract: The present disclosure generally pertains to formulations containing two or more fat-soluble vitamins, lemon oil, and zinc. Also disclosed are kits containing such formulations and methods for administering such formulations to treat malabsorption in subjects diagnosed with CF, Crohn's Disease, Colitis, Irritable Bowel Syndrome, Celiac Disease, and other like conditions.
    Type: Grant
    Filed: May 15, 2014
    Date of Patent: September 13, 2016
    Assignee: MVW Nutritionals, Inc.
    Inventor: Michael J. Walters
  • Patent number: 9266838
    Abstract: In one aspect, the invention relates to substituted (E)-N?-(1-phenylethylidene)benzohydrazide analogs, derivatives thereof, and related compounds, which are useful as inhibitors of lysine-specific histone demethylase, including LSD1; synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of using the compounds and compositions to treat disorders associated with dysfunction of the LSD1. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Grant
    Filed: June 19, 2013
    Date of Patent: February 23, 2016
    Assignee: University of Utah Research Foundation
    Inventors: Hariprasad Vankayalapati, Venkataswamy Sorna, Steven L. Warner, Bret Stephens, David J. Bearss, Sunil Sharma
  • Patent number: 9198894
    Abstract: The present invention relates to the preparation of anti-tumor drugs with andrographolide derivatives, which belongs to the field of pharmaceutical technology, and involves 15-benzylidene substituted derivatives of 14-deoxy-11,12-didehydro-andrographolide and their 3,19-ester derivatives. Proved by the experiments, these compounds significantly inhibited the colony formation and migration ability of various cancer cells, and also inhibited the migration ability of vascular endothelial cells in vitro. The compounds of this invention significantly inhibited the tumor growth, invasion, metastasis and angiogenesis on mouse xenograft models, and inhibited the experimental lung metastasis of B16-F10 malignant melanoma cells. Therefore, this class of compounds could be used as the active ingredients for the preparation of antineoplastic drugs, which are of efficiency and low-toxicity.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: December 1, 2015
    Assignee: Zhengzhou University
    Inventors: Fengjuan Wu, Guifu Dai, Haiwei Xu, Zhiwen Jiang, Liping Zhu, Lijun Yan, Hongmin Liu, Yanan Wang, Weiyi Li, Ruijing Dong
  • Patent number: 9050359
    Abstract: Disclosed herein are herbal formulations for relief from symptoms of skin disease. The formulations can also be combined with an active or inactive pharmaceutical ingredient, and/or a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: June 9, 2015
    Assignee: Haus Bioceuticals Inc.
    Inventors: Tomy Yesudas, Philip Alex, Michael Centola, Adam Joshua Payne
  • Publication number: 20150147411
    Abstract: The present invention relates to a composition for preventing or treating colitis. According to one embodiment of the present invention, the composition for preventing or treating colitis comprises S-allyl-L-cysteine, a pharmaceutically acceptable salt thereof, or a solvate or hydrate of the same as an active ingredient, and exhibits an anti-inflammatory action in colitis. The composition for preventing or treating colitis has outstanding effects in preventing and alleviating colitis due to the effect of the anti-inflammatory action and the effect of an antioxidant action of S-allyl-L-cysteine, while at the same time S-allyl-L-cysteine is not accompanied by side-effects, therefore, has a wide scope of use against colitis.
    Type: Application
    Filed: July 3, 2013
    Publication date: May 28, 2015
    Applicant: PHARMAKING CO., LTD.
    Inventors: Soon Bae Kim, Gwang Soon Kim, Wan Bae Kim, Wie Jong Kwak, Sun Duck Jeon, Hyung Young Yoon, Ki Baik Hahm, Eun Hee Kim
  • Patent number: 9028851
    Abstract: The present invention is directed to a hemostatic material comprising a scaffold and a galvanic particulate. The galvanic particulate comprises particles made of at least two dissimilar metals. The scaffold is preferably a biocompatible polysaccharide-based hemostatic, such as a chitosan or cellulosic based hemostatic like ORC.
    Type: Grant
    Filed: December 21, 2011
    Date of Patent: May 12, 2015
    Assignee: Ethicon, Inc.
    Inventors: Yi-Lan Wang, Ying Sun, Guanghui Zhang, Chunlin Yang
  • Patent number: 8968791
    Abstract: The present invention provides a dietary supplement that promote the growth, repair, and maintenance of mammalian bone and joint connective tissue. In particular, the dietary supplement comprises a combination of at least one metal chelate and at least one chondroprotective agent.
    Type: Grant
    Filed: May 30, 2008
    Date of Patent: March 3, 2015
    Assignee: Novus International, Inc.
    Inventors: Jeremy D. Moore, Thomas R. Hampton, Robert Harrell
  • Patent number: 8968758
    Abstract: The present invention provides a method for preparing a material in the form of liquid for forming an antimicrobial surface coating with multi-level antimicrobial properties, comprising: encapsulating one or more volatile or gaseous biocides in two or more amphiphilic block copolymers to obtain a w/o/w double emulsion, and mixing the w/o/w double emulsion with one or more nonvolatile biocides, each of which is selected from the group consisting of a metal containing biocide, triclosan, a carboxylic acid, a sugar acid and a combination thereof.
    Type: Grant
    Filed: April 15, 2014
    Date of Patent: March 3, 2015
    Assignee: The Hong Kong University of Science and Technology
    Inventors: King Lun Yeung, Wai Kin Leung
  • Publication number: 20150050261
    Abstract: The present invention relates to dietary and nutritional supplements comprising various vitamins, minerals and nutrients, including an omega-3 fatty acid of plant-based origin and a folate derivative.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 19, 2015
    Inventors: Chris G. Evenstad, Kelly M. Heimerl, Mike J. McBride, Ronnie Ortiz, Carrol J. Rhead, Sami Yusuf, Michelle B. Zachman
  • Patent number: 8932647
    Abstract: A functional beverage that can be used by athletes and bodybuilders for restoring human growth hormones using an HGH precursor. The composition includes water, sweeteners, acids, gums, natural colorants, natural flavors, including pantothenic acid, chromium, copper, choline, and boron. The composition also includes selected amino acids such as L-Leucine, L-Isoleucine, L-Valine, and L-Arginine.
    Type: Grant
    Filed: August 11, 2013
    Date of Patent: January 13, 2015
    Inventor: Carol Vandell
  • Patent number: 8927029
    Abstract: Disclosure is provided for methods of preventing, removing or inhibiting microbial biofilm formation or microbial infection in a plant or plant part thereof, including applying thereto a treatment effective amount of an active compound as described herein, or an agriculturally acceptable salt thereof. Methods of enhancing a microbicide (e.g., including a copper, antibiotic, bacteriophage, etc.) and/or plant defense activator are also provided, including applying an active compound as described herein. Compositions comprising an active compound as described herein in an agriculturally acceptable carrier are also provided, and in some embodiments the compositions further include a microbicide (e.g., including copper, antibiotic, bacteriophage, etc.) and/or plant defense activator.
    Type: Grant
    Filed: November 25, 2013
    Date of Patent: January 6, 2015
    Assignee: North Carolina State University
    Inventors: Christian Melander, John Cavanagh, David Ritchie, Robert W. Huigens, III, T. Eric Ballard, Justin J. Richards, Thomas W. Lindsey, Jonathan S. Lindsey
  • Publication number: 20140370120
    Abstract: The present invention relates to methods of maintaining, and methods of restoring, a desired calcium homeostasis in a non-human terrestrial animal by administering an effective amount of one or more Calcium-Sensing Receptor modulators (CaSRs) to the animal. The invention further provides methods of reducing foot lesions in chickens. The invention also relates to food compositions useful in the methods of the invention.
    Type: Application
    Filed: January 6, 2014
    Publication date: December 18, 2014
    Applicant: MariCal, Inc.
    Inventors: H. William Harris, JR., Marlies Betka, Chris Frederick Holm, Steven Harold Jury
  • Patent number: 8911793
    Abstract: Systems and methods are described that facilitate generating and storing a concentrated copper and silver ion solution for treating a remote water volume (e.g., a pool, fountain, hot tub, cooling tower, etc.), in accordance with various features described herein. Citric acid and a water-soluble binding polymer are added to a volume of water. The intermediate solution is circulated past an ion generator for a predetermined time period, and copper ions generated thereby are bound by the binding polymer and/or chelated by the citric acid. Once a desired concentration of copper ions has been achieved, the concentrated solution is stored in portable vessels for transport to the remote water volume. Concentrated solution is added to the remote water volume to achieve a concentration therein of approximately 0.2-0.3 ppm.
    Type: Grant
    Filed: November 16, 2010
    Date of Patent: December 16, 2014
    Inventor: George Loucaides
  • Patent number: 8883221
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2014
    Assignee: Bausch & Lomb Incorporated
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Patent number: 8877244
    Abstract: The present invention provides a stabilized pesticidal composition comprising at least one granular substrate material containing at least one metal chelate of 2-(2?-nitro-4?-methylsulphonylbenzoyl)-1,3-cyclohexanedione, a method of producing a stabilized granular pesticidal composition which comprises incorporating a metal chelate of 2-(2?-nitro-4?-methylsulphonylbenzoyl)-1,3-cyclohexanedione in to or on to a granular substrate material; and a method of killing or controlling weeds or unwanted vegetation (without damaging beneficial plants and or seeds) which comprises applying a herbicidally effective amount of the stabilized granular pesticide composition of the invention to the foliage, tissue or locus of the weeds or unwanted vegetation.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: November 4, 2014
    Assignee: Syngenta Crop Protection LLC
    Inventors: John R. James, Andrew Pearson, Johnny D. Reynolds
  • Publication number: 20140323305
    Abstract: The present invention relates to the use of strobilurine type compounds of formula I and the N-oxides and the salts thereof for combating phytopathogenic fungi containing a mutation in the mitochondrial cytochrome b gene conferring resistance to Qo inhibitors, and to methods for combating such fungi. The invention also relates to novel compounds, processes for preparing these compounds, to compositions comprising at least one such compound, to plant health applications, and to seeds coated with at least one such compound.
    Type: Application
    Filed: December 6, 2012
    Publication date: October 30, 2014
    Applicant: BASF SE
    Inventors: Joachim Rheinheimer, Violeta Terteryan, Stefan Redlich, Doris Kremzow, Claudia Rosenbaum, Sebastian Georgios Rohrer, Wassilios Grammenos, Christian Pilger, Franz Roehl, Markus Gewehr, Gerd Stammler, Jurith Montag, Hubert Sauter
  • Publication number: 20140314874
    Abstract: This pill has the effect of increasing penis size in length and width in male mostly when erected and while flaccid too.
    Type: Application
    Filed: April 19, 2013
    Publication date: October 23, 2014
    Inventor: Ronald Chaccour
  • Publication number: 20140308265
    Abstract: The claimed invention is directed to compositions and methods effective in preventing microbial contamination or reducing microbial count associated with a contaminated surface, comprising a biocidal system comprised of a primary biocide, a pH buffer agent, a surfactant, all in an aqueous based carrier, wherein the compositions may be considered environmentally friendly.
    Type: Application
    Filed: November 6, 2012
    Publication date: October 16, 2014
    Inventors: Burt R. Sookram, John W. Veenstra
  • Patent number: 8840910
    Abstract: There is provided an antifouling coating composition capable of forming an antifouling coating film which has stable coating film consumption degree on ships, underwater structures and the like and which exhibits excellent antifouling property over a long term. The antifouling coating composition includes a hydrolyzable copolymer (A) and an antifouling agent (B), wherein the hydrolyzable copolymer (A) is, e.g., a metal salt bond-containing copolymer having a component unit derived from a monomer (a21) represented by the general formula (II): CH2?C(R2)—COO-M-O—CO—C(R2)?CH2??(II) [In the formula (II), M is zinc or copper, and R2 is a hydrogen atom or a methyl group], and a component unit derived from other unsaturated monomer (a22) copolymerizable with the monomer (a21), and wherein the antifouling agent (B) includes at least medetomidine.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: September 23, 2014
    Assignee: Chugoku Marine Paints, Ltd.
    Inventors: Satoshi Masuda, Yusuke Hayashi, Yukio Kozono
  • Publication number: 20140271558
    Abstract: Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Cappellos, Inc.
    Inventor: John V. Cappello
  • Publication number: 20140255509
    Abstract: Compositions and formulations comprising a non-neutralised tocol phosphate and a vitamin A compound, which are suitable for the treatment of inflammation and/or infection in breast or udder tissue, more particularly in a mammary gland, reducing the somatic cell count in a lactating subject and supplementing vitamin E levels in a subject.
    Type: Application
    Filed: March 2, 2012
    Publication date: September 11, 2014
    Applicant: PHOSPHAGENICS LIMITED
    Inventors: Roksan Libinaki, Robert Lee Neely
  • Publication number: 20140248374
    Abstract: Embodiments of the invention relate to a composition containing zinc and copper and methods of using the same in treatment of exposure to a pore-forming toxin (PFT) in a subject or membrane perturbant (MP).
    Type: Application
    Filed: February 21, 2012
    Publication date: September 4, 2014
    Applicant: UNIVERSITY OF HAWAII
    Inventor: Angel Anne YANAGIHARA
  • Publication number: 20140221948
    Abstract: The subject matter of the invention is a hygienic or health care article having a content of hydroactive polymers and a content of copper or copper ions.
    Type: Application
    Filed: February 13, 2014
    Publication date: August 7, 2014
    Inventor: Birgit Riesinger
  • Patent number: 8785379
    Abstract: Pest controlling compositions exhibiting enhanced pesticidal activity levels are disclosed. In one embodiment, a composition includes at least one pesticide, at least one transition metal salt and at least one proteinaceous material. In this embodiment, the composition exhibits enhanced pesticidal activity levels compared to a composition dissimilar only in not having the at least one transition metal salt and the at least one proteinaceous material.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: July 22, 2014
    Assignee: Dow AgroSciences, LLC.
    Inventors: Stephen L. Wilson, Lei Liu, James D. Thomas, Raymond E. Boucher, Jr., James E. Dripps, Margaret S. Kempe
  • Patent number: 8785662
    Abstract: The present invention relates to a preservative for preserving wood comprising 5-methyl-2-trifluoromethylfuran-3-carboxylic acid anilide derivative represented by the following formula, wherein R represents an iropropyl group or an isopropoxy group as an active ingredient. The preservative for preserving wood has an excellent preservative effect on various wood-decay fungi at an extremely low dose, is economically efficient, and imposes a small burden on the environment. The present invention also relates to a method for treating wood using the preservative.
    Type: Grant
    Filed: May 12, 2010
    Date of Patent: July 22, 2014
    Assignee: SDS Biotech K.K.
    Inventors: Keijitsu Tanaka, Masahiro Maesawa
  • Publication number: 20140200136
    Abstract: The present invention relates to pesticidal mixtures comprising as active compounds 1) at least one pesticidal active 3-arylquinazolin-4-one compound I of formula (I): wherein R1, R2, R3, R4, k and n are defined in the description; and 2) at least one fungicidal compounds II selected from azoles, strobilurins, carboxamides, carbamates, heterocyclic and various other compounds as defined in the description, in synergistically effective amounts. The invention relates further to methods and use of these mixtures for combating insects, arachnids or nematodes and harmful fungis in and on plants, and for protecting such plants being infested with pests, especially also for protecting seeds.
    Type: Application
    Filed: August 31, 2012
    Publication date: July 17, 2014
    Applicant: BASF SE
    Inventors: Florian Kaiser, Steffen Gross, Egon Haden, Arun Narine
  • Publication number: 20140186464
    Abstract: The present invention provides a sepsis therapeutic drug useful for prophylaxis and treatment of sepsis. A prophylactic agent and/or a therapeutic agent for sepsis containing 5-aminolevulinic acid (5-ALA) or a derivative thereof or a pharmacologically acceptable salt of 5-ALA or the derivative as an active ingredient is prepared. The prophylactic agent and/or the therapeutic agent preferably contains a metal-containing compound such as ferrous sodium citrate in addition to the ALAs. Preferred examples of the ALAs include ALA; various esters of ALA such as methyl, ethyl, propyl, butyl, and pentyl esters; and hydrochlorides, phosphates, sulfates of ALA and the esters.
    Type: Application
    Filed: August 10, 2012
    Publication date: July 3, 2014
    Applicants: NIHON UNIVERSITY, SBI Pharmaceuticals Co., Ltd.
    Inventors: Kosaku Kinoshita, Katsuhisa Tanjoh, Akihiro Noda, Atsushi Sakurai, Tohru Tanaka, Kiwamu Takahashi, Motowo Nakajima, Fuminori Abe
  • Publication number: 20140161905
    Abstract: Liquid treatment compositions comprise (or in certain preferred embodiments may consist essentially of, or may consist of): a copper source material which releases copper ions into the treatment composition, at least one alcohol which independently of other constituents present exhibits a microbicidal effect, at least one quaternary ammonium compound which provides a microbicidal benefit, optionally but very preferably also at least one detersive surfactant, further optionally one or more further constituents which impart one or more advantageous technical or aesthetic benefits to the compositions, including one or more detersive surfactants, and water, wherein the compositions are at a pH such that the surface treatment compositions, exhibit a microbicidal or germicidal or antimicrobial effect on treated inanimate surfaces or when used to treat an airspace, e.g.
    Type: Application
    Filed: May 18, 2012
    Publication date: June 12, 2014
    Applicant: Reckitt Benckiser LLC
    Inventors: Mohammad Khalid Ijaz, Joseph Rubino, Yun-Peng Zhu